During the past decade, University of Virginia - Nephrology Clinical Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia - Nephrology Clinical Research Center" #1 sponsor was "Keryx Biopharmaceuticals" with 2 trials, followed by "Anesiva, Inc." with 1 trials sponsored, "Kadmon Corporation, LLC" with 1 trials sponsored, "Kadmon, a Sanofi Company" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia - Nephrology Clinical Research Center" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia - Nephrology Clinical Research Center" are "Hyperphosphatemia" (2 trials), "Kidney Failure" (2 trials), "Autosomal Dominant Polycystic Kidney Disease (ADPKD)" (1 trials), "Chronic Renal Failure" (1 trials) and "ESRD" (1 trials). Many other conditions were trialed in "University of Virginia - Nephrology Clinical Research Center" in a lesser frequency.

Most popular intervention types in "University of Virginia - Nephrology Clinical Research Center" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Tesevatinib" (1 trials), "Tolvaptan" (1 trials), "edifoligide (E2F Decoy)" (1 trials) and "ferric citrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia - Nephrology Clinical Research Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Virginia - Nephrology Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Virginia - Nephrology Clinical Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia - Nephrology Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".